Haczku, Angela
- Lignamed, LLC (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
FY2021 NIH rank #9,766
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2003 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2021
Linked Award Amount
$964.3K
Full award amounts, FY2021
Award Records
1
Records listing this PI
Award-Linked Rank
#9,766
By linked amount among FY2021 PIs
Earliest Year Loaded
2003
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2021 award records by amount
NIH award records listing Haczku, Angela as a PI. Multi-PI records show the full award amount for context.
- 5R42AI132012-04R42Contact PIIND enabling development of LGM2605 as adjuvant treatment for asthma$964.3Kaward amount
Award organization
Organizations that administered FY2021 awards listing Haczku, Angela as a PI.
FY2021 award administered by Lignamed, LLC ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2003First NIH AwardLignamed, LLC
- 2004$500K Cumulative Funding
- 2013$1M Cumulative Funding
- 2019$2M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #8145